We are live on ! Find out more
FIM

Fernwood Investment Management Portfolio holdings

AUM $288M
1-Year Est. Return 33.54%
This Fund
S&P 500
This Quarter Est. Return
+8.46%
1 Year Est. Return
+33.54%
3 Year Est. Return
+83.37%
5 Year Est. Return
+196.85%
10 Year Est. Return
+650.16%
AUM
$242M
AUM Growth
+$4.67M
Cap. Flow
-$8.98M
Cap. Flow %
-3.72%
Top 10 Hldgs %
29.52%
Holding
191
New
6
Increased
46
Reduced
60
Closed
9

Sector Composition

Rank Sector Weight
1 Healthcare 17.82%
2 Technology 11.47%
3 Energy 11.25%
4 Financials 7.65%
5 Consumer Discretionary 7.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TPL icon
1
Texas Pacific Land
TPL
$24.1B
$18.1M 7.48%
69,480
-324
-0.5% -$85.9K
IVV icon
2
iShares Core S&P 500 ETF
IVV
$901B
$8.39M 3.47%
21,839
+153
+0.7% +$59K
AAPL icon
3
Apple
AAPL
$4.56T
$8.35M 3.45%
64,239
-331
-0.5% -$47.3K
PLRX icon
4
Pliant Therapeutics
PLRX
$65M
$5.89M 2.44%
304,573
+81,816
+37% +$1.71M
MGK icon
5
Vanguard Morningstar Mega Cap Growth ETF
MGK
$34.1B
$5.64M 2.33%
163,920
-2,110
-1% -$75.6K
IYK icon
6
iShares US Consumer Staples ETF
IYK
$1.41B
$5.62M 2.33%
83,175
+60
+0.1% +$3.95K
LLY icon
7
Eli Lilly
LLY
$1.05T
$5.21M 2.15%
14,233
+15
+0.1% +$5.32K
CVS icon
8
CVS Health
CVS
$122B
$5.07M 2.1%
54,376
+4
+0% +$386
MDB icon
9
MongoDB
MDB
$31.8B
$4.62M 1.91%
23,457
+693
+3% +$123K
ARCC icon
10
Ares Capital
ARCC
$14.3B
$4.49M 1.86%
242,986
+4,089
+2% +$76.8K
DGRO icon
11
iShares Core Dividend Growth ETF
DGRO
$43.5B
$4.47M 1.85%
89,325
+9,935
+13% +$488K
MSCI icon
12
MSCI
MSCI
$40.9B
$4.06M 1.68%
8,720
+864
+11% +$402K
AMZN icon
13
Amazon
AMZN
$2.96T
$3.74M 1.55%
44,578
+875
+2% +$86.4K
GOOGL icon
14
Alphabet (Google) Class A
GOOGL
$4.34T
$3.7M 1.53%
41,985
-85
-0.2% -$8.08K
JNJ icon
15
Johnson & Johnson
JNJ
$619B
$3.57M 1.48%
20,225
-45
-0.2% -$7.77K
PM icon
16
Philip Morris
PM
$295B
$3.22M 1.33%
31,802
+203
+0.6% +$19.2K
UNP icon
17
Union Pacific
UNP
$174B
$3.1M 1.28%
14,968
+426
+3% +$87.4K
MO icon
18
Altria Group
MO
$114B
$3.07M 1.27%
67,192
+605
+0.9% +$27.4K
V icon
19
Visa
V
$675B
$2.88M 1.19%
13,879
-60
-0.4% -$12.1K
IRDM icon
20
Iridium Communications
IRDM
$5.27B
$2.87M 1.19%
55,872
-4,250
-7% -$213K
RLAY icon
21
Relay Therapeutics
RLAY
$4.23B
$2.76M 1.14%
185,063
IJH icon
22
iShares Core S&P Mid-Cap ETF
IJH
$127B
$2.64M 1.09%
54,480
-3,100
-5% -$150K
IWB icon
23
iShares Russell 1000 ETF
IWB
$50B
$2.63M 1.09%
12,473
META icon
24
Meta Platforms (Facebook)
META
$1.51T
$2.62M 1.09%
21,807
-75
-0.3% -$8.81K
IWM icon
25
iShares Russell 2000 ETF
IWM
$83B
$2.44M 1.01%
14,012
-1,044
-7% -$186K

Similar funds

Fernwood Investment Management's Q4 2022 Portfolio in Review

As of Q4 2022, Fernwood Investment Management held 191 positions worth $242M, up 2% from $237M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Fernwood Investment Management withdrew a net $8.98M in Q4 2022, closing 9 positions and reducing 60 holdings. Its most notable exit was Global Blood Therapeutics, Inc., an estimated $11.9M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, down from 22% a quarter earlier, followed by Technology and Energy.

Against the trend, Fernwood Investment Management opened a new position in Revolution Medicines worth $336K.

  • Fernwood Investment Management's largest Q4 2022 buy was Revolution Medicines: 14,125 shares worth $336K.
  • Fernwood Investment Management added most to Pliant Therapeutics in Q4 2022, an estimated $1.71M increase.
  • Fernwood Investment Management's biggest Q4 2022 reduction was Iridium Communications, cutting an estimated $213K.
  • Fernwood Investment Management fully exited Global Blood Therapeutics, Inc. in Q4 2022, selling an estimated $11.9M.
  • Fernwood Investment Management's ten largest holdings make up 30% of its $242M portfolio in Q4 2022.
  • Fernwood Investment Management opened 6 new positions and closed 9 in Q4 2022.
  • Fernwood Investment Management's portfolio value rose 2% quarter-over-quarter to $242M.

Based on Fernwood Investment Management's 13F filing for Q4 2022, filed 7 Feb 2023.